AIMC Topic: Muscular Dystrophy, Facioscapulohumeral

Clear Filters Showing 1 to 4 of 4 articles

Deep learning-based acceleration of muscle water T2 mapping in patients with neuromuscular diseases by more than 50% - translating quantitative MRI from research to clinical routine.

PloS one
BACKGROUND: Quantitative muscle water T2 (T2w) mapping is regarded as a biomarker for disease activity and response to treatment in neuromuscular diseases (NMD). However, the implementation in clinical settings is limited due to long scanning times a...

Machine learning-driven Heckmatt grading in facioscapulohumeral muscular dystrophy: A novel pathway for musculoskeletal ultrasound analysis.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
OBJECTIVE: This study introduces a machine learning approach to automate muscle ultrasound analysis, aiming to improve objectivity and efficiency in segmentation, classification, and Heckmatt grading.

AI driven analysis of MRI to measure health and disease progression in FSHD.

Scientific reports
Facioscapulohumeral muscular dystrophy (FSHD) affects roughly 1 in 7500 individuals. While at the population level there is a general pattern of affected muscles, there is substantial heterogeneity in muscle expression across- and within-patients. Th...

A deep learning tool without muscle-by-muscle grading to differentiate myositis from facio-scapulo-humeral dystrophy using MRI.

Diagnostic and interventional imaging
PURPOSE: The purpose of this study was to assess the capabilities of a deep learning (DL) tool to discriminate between type 1 facioscapulo-humeral dystrophy (FSHD1) and myositis using whole-body muscle magnetic resonance imaging (MRI) examination wit...